Sensex Closes 40 Points Higher, Nifty Settles At 10,530: 10 Things To Know
- Twenty three stocks on the 50-scrip index finished the day higher.
- Top gainers on the 50-scrip index Nifty included Yes Bank, Tata Consultancy Services (TCS) and Sun Pharma, closing between 1.4 per cent and 2.2 per cent higher.
- Market breadth favoured the rise in markets, with 856 stocks on the NSE finishing higher, against the same number of shares closing lower. On the BSE, 1,284 stocks advanced and 1,274 declined.
- Besides TCS, gains in Infibeam - which finished nearly 11 per cent higher - contributed to a 0.7 per cent rise in the Nifty IT index.
- Tata Motors shares ended 1.3 per cent higher, after hitting a four-week high during the session. The spike in Tata Motors shares came after data from a UK auto trade association showed a surge in Jaguar registrations in October.
- GAIL (India) extended gains into a third session, to finish 0.8 per cent higher, a day after the state-run gas utility reported a 50 per cent jump in net profit for the July-September period.
- Shares in miner Vedanta, which traded ex-dividend, finished 1.1 per cent higher.
- On the other hand, shares in PSU banking major State Bank of India (SBI) ended 2.9 per cent lower, while those of private-sector lender Axis Bank fell 2.7 per cent.
- The domestic markets tracked gains in Asian peers, which were supported by gains on Wall Street although the trading sentiment was tempered ahead of the US midterm elections. That would mark the first major electoral test of US President Donald Trump's big tax cuts and hostile trade policies since assuming office.
- Stock exchange BSE will conduct a special trading session on Wednesday on account of the Diwali festival. Trading will commence at 5:30 pm and end at 6:30 pm, the bourse has said.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
